SRDX - SurModics - Biotech IPO | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
SRDX - SurModics - Biotech IPO

An SI Board Since March 1998

Posts	SubjectMarks	Bans	Symbol
65	6	0	SRDX

Emcee: Will Preska	Type: Unmoderated

Introduction Market Data Compact

SurModics is a supplier to some of the large biotech firms, such as Medtronic. SRDX IPO'd at $7.50, and the stock is moving up. They seem to have a lot of potential for growth. Comments?

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
65	"..."We are delighted with our progress towards achieving a PMA for th	Lance Bredvold	-	March 28
64	I've never understood why SRDX stock seems so bouyant. Good steady earnings	Lance Bredvold	-	February 27
63	I need to remind myself that SurVeil is not the only arrow in SRDX's quiver.	Lance Bredvold	-	January 19
62	Well, that's a bummer. Premarket approval delayed by FDA request for more d	Lance Bredvold	-	January 19
61	And one more thing to keep in mind. I've always been impressed that neither	Lance Bredvold	1	4/28/2022
60	Wow. Did I just hear Gary say they have 19 sales professionals at the end of 2n	Lance Bredvold	-	4/27/2022
59	Finally selling below $40 after today's earnings report. I had expected the	Lance Bredvold	-	4/27/2022
58	I guess what this means is that SRDX is now more of a "story stock".	Lance Bredvold	-	11/15/2021
57	I've liked the way Gary Maharaj speaks, clearly and without exaggeration. T	Lance Bredvold	-	11/14/2021
56	New imaging agent for Alzheimers licensed to Amersham/GE. Last evening earnin	Lance Bredvold	-	1/22/2004
55	Article by Aron Anderson on intravitreal drug delivery. From Sept 1. Thanks to	Lance Bredvold	-	1/10/2004
54	NitroMed nitric oxide PR for stents by: skiplarson98 (55/M/Montana) 01/08/04 12	Lance Bredvold	-	1/8/2004
53	Patent search: This effort becoming a compendium of helpful posts by foolishprem	Lance Bredvold	-	1/4/2004
52	Lance, Just wanted to say thx for posting ... your objective of just showing key	cooksbay95	-	12/17/2003
51	Oct2002 review panel of the cypher sirolimus stent questions and discussion was	Lance Bredvold	-	12/15/2003
50	New York Times summary of FDA Cypher warning, reasons, reactions, possible solut	Lance Bredvold	-	11/23/2003
49	fda.gov nyf2000 provided this link to the FDA advisory panels agenda and invita	Lance Bredvold	-	11/16/2003
48	Nitinol home page has good descriptions of stents and I read an article on BX (b	Lance Bredvold	-	11/12/2003
47	Trends in Medicine article from Nov. 2002 reporting committee review of the cyph	Lance Bredvold	-	11/12/2003
46	NIH awards from 1998 apparently. URL presented by Aslan on Yahoo, a total of ju	Lance Bredvold	-	11/4/2003
45	An unabashedly positive outlook from MBA investor on Yahoo. I post it here beca	Lance Bredvold	-	11/4/2003
44	A July discussion of the blood clot (thrombus) issue pointed out by JNJ. The ar	Lance Bredvold	-	11/4/2003
43	Boston Globe article which demonstrates to me that the biggest mistake in the wh	Lance Bredvold	-	11/2/2003
42	Bloomberg News article about FDA warning published in the Minneapolis paper and	Lance Bredvold	-	10/30/2003
41	another resource and excellent discussion from Foolish Premise on hypersensitivi	Lance Bredvold	-	10/30/2003

Go to reply# or date (mm/dd/yy):